Quantification of CD133+CD34+ cells in proliferating hemangioma
. | Hemangioma specimen . | Patient sex . | Patient age, mo . | Tumor first noted . | CD34+, % . | CD133+CD34+, % . | CD133+KDR+, % . |
---|---|---|---|---|---|---|---|
1 | 38 | F | 7 | 2 wk after birth | 45.2 | 0.18 | ND |
2 | 39 | M | 7 | 3 wk after birth | 23.2 | 0.10 | ND |
3 | 41 | F | 4 | At birth | 27.2 | 21.40 | ND |
4 | 46 | F | 5 | At birth | 21.6 | 0.00 | ND |
5 | 49 | F | 15 | 1 wk after birth | 34.3 | 0.15 | ND |
6 | 53 | M | 9 | 2 mo after birth | 49.9 | 0.67 | ND |
7 | 54 | F | 19 | 8 d after birth | 69.9 | 2.91 | ND |
8 | 61 | F | 3 | 2 wk after birth | 53.4 | 1.62 | ND |
9 | 73 | F | 4 | 2-3 d after birth | 50.3 | 0.20 | 0.17 |
10 | 74 | F | 6 | At birth | 34.6 | 0.17 | 0.14 |
11 | 75 | F | 15 | 2-3 d after birth | 37.8 | 2.15 | 1.60 |
12 | 77 | F | 24 | At birth | 69.4 | 0.23 | 0.22 |
. | Hemangioma specimen . | Patient sex . | Patient age, mo . | Tumor first noted . | CD34+, % . | CD133+CD34+, % . | CD133+KDR+, % . |
---|---|---|---|---|---|---|---|
1 | 38 | F | 7 | 2 wk after birth | 45.2 | 0.18 | ND |
2 | 39 | M | 7 | 3 wk after birth | 23.2 | 0.10 | ND |
3 | 41 | F | 4 | At birth | 27.2 | 21.40 | ND |
4 | 46 | F | 5 | At birth | 21.6 | 0.00 | ND |
5 | 49 | F | 15 | 1 wk after birth | 34.3 | 0.15 | ND |
6 | 53 | M | 9 | 2 mo after birth | 49.9 | 0.67 | ND |
7 | 54 | F | 19 | 8 d after birth | 69.9 | 2.91 | ND |
8 | 61 | F | 3 | 2 wk after birth | 53.4 | 1.62 | ND |
9 | 73 | F | 4 | 2-3 d after birth | 50.3 | 0.20 | 0.17 |
10 | 74 | F | 6 | At birth | 34.6 | 0.17 | 0.14 |
11 | 75 | F | 15 | 2-3 d after birth | 37.8 | 2.15 | 1.60 |
12 | 77 | F | 24 | At birth | 69.4 | 0.23 | 0.22 |
ND indicates not determined.